Generated Narrative: CodeSystem research-study-purpose-type

This case-sensitive code system http://terminology.hl7.org/CodeSystem/research-study-purpose-type defines the following codes:

CodeDisplayDefinition
treatment Treatment StudyOne or more interventions are being evaluated for treating a disease, syndrome, or condition.
prevention Prevention StudyOne or more interventions are being evaluated for preventing the development of a disease or condition.
diagnostic Diagnostic StudyOne or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass.
screening Screening StudyOne or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns.
supportive-care Supportive Care StudyOne or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function.
health-services-research Health Services ResearchAn investigation for evaluating the delivery, processes, management, organization, or financing of health care.
basic-science Basic ScienceAn investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention.
device-feasibility Device Feasibility StudyAn intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial.
safety Safety StudyOne or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)
risk-association Risk Association StudyOne or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)
efficacy Efficacy StudyOne or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition.
pharmacokinetic Pharmacokinetic StudyA study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body.
pharmacodynamic Pharmacodynamic StudyA study of the mechanism of drug action, biochemical effect, or physiological effect of a drug.
bioequivalence Bioequivalence StudyA study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable.
dose-response Dose-Response StudyA study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response.
pharmacogenetic Pharmacogenetic StudyA study evaluating how specific gene variations affect individual drug responses.
pharmacogenomic Pharmacogenomic StudyA study evaluating how multiple gene variations affect individual drug responses.
pharmacoeconomic Pharmacoeconomic StudyA study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses.
incidence Incidence StudyA study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time.
prevalence Prevalence StudyA study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time.
prediction Prediction StudyOne or more methods are being evaluated for use in predicting the risk of a disease or condition.
 <status value="active"/> <experimental value="false"/> <date value="2026-04-14T16:55:11+11:00"/> <publisher value="Health Level Seven International"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> <telecom> <system value="email"/> <value value="hq@HL7.org"/> </telecom> </contact> <description value="Codes for the intent of the study."/> <copyright value="This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license"/> <caseSensitive value="true"/> <valueSet value="http://terminology.hl7.org/ValueSet/research-study-purpose-type"/> <content value="complete"/> <concept> <code value="treatment"/> <display value="Treatment Study"/> <definition value="One or more interventions are being evaluated for treating a disease, syndrome, or condition."/> </concept> <concept> <code value="prevention"/> <display value="Prevention Study"/> <definition value="One or more interventions are being evaluated for preventing the development of a disease or condition."/> </concept> <concept> <code value="diagnostic"/> <display value="Diagnostic Study"/> <definition value="One or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass."/> </concept> <concept> <code value="screening"/> <display value="Screening Study"/> <definition value="One or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns."/> </concept> <concept> <code value="supportive-care"/> <display value="Supportive Care Study"/> <definition value="One or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function."/> </concept> <concept> <code value="health-services-research"/> <display value="Health Services Research"/> <definition value="An investigation for evaluating the delivery, processes, management, organization, or financing of health care."/> </concept> <concept> <code value="basic-science"/> <display value="Basic Science"/> <definition value="An investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention."/> </concept> <concept> <code value="device-feasibility"/> <display value="Device Feasibility Study"/> <definition value="An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial."/> </concept> <concept> <code value="safety"/> <display value="Safety Study"/> <definition value="One or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)"/> </concept> <concept> <code value="risk-association"/> <display value="Risk Association Study"/> <definition value="One or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)"/> </concept> <concept> <code value="efficacy"/> <display value="Efficacy Study"/> <definition value="One or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition."/> </concept> <concept> <code value="pharmacokinetic"/> <display value="Pharmacokinetic Study"/> <definition value="A study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body."/> </concept> <concept> <code value="pharmacodynamic"/> <display value="Pharmacodynamic Study"/> <definition value="A study of the mechanism of drug action, biochemical effect, or physiological effect of a drug."/> </concept> <concept> <code value="bioequivalence"/> <display value="Bioequivalence Study"/> <definition value="A study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable."/> </concept> <concept> <code value="dose-response"/> <display value="Dose-Response Study"/> <definition value="A study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response."/> </concept> <concept> <code value="pharmacogenetic"/> <display value="Pharmacogenetic Study"/> <definition value="A study evaluating how specific gene variations affect individual drug responses."/> </concept> <concept> <code value="pharmacogenomic"/> <display value="Pharmacogenomic Study"/> <definition value="A study evaluating how multiple gene variations affect individual drug responses."/> </concept> <concept> <code value="pharmacoeconomic"/> <display value="Pharmacoeconomic Study"/> <definition value="A study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses."/> </concept> <concept> <code value="incidence"/> <display value="Incidence Study"/> <definition value="A study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time."/> </concept> <concept> <code value="prevalence"/> <display value="Prevalence Study"/> <definition value="A study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time."/> </concept> <concept> <code value="prediction"/> <display value="Prediction Study"/> <definition value="One or more methods are being evaluated for use in predicting the risk of a disease or condition."/> </concept> </CodeSystem>